FDA approves an investigational new (oral) drug application that may allow people with celiac to consume gluten

Another (oral) therapeutic treatment for celiac disease is in the works!

The FDA approved an IND (investigational new drug) application from ActoBio for AG017, an oral biologic drug candidate.

Learn more here: https://www.biopharma-reporter.com/Article/2019/08/29/FDA-approves-IND-for-oral-biologic-to-treat-celiac-disease?utm_source=copyright&utm_medium=OnSite&utm_campaign=copyright

Read ActoBio’s Press Release here

Related Posts Plugin for WordPress, Blogger...

On September 11th, 2019, posted in: CeliacCorner Blogs by

Leave a comment - awaits moderation

Your email address will not be published. Required fields are marked *